NIHR national Patient Recruitment Centres (PRCs) are dedicated to setting up and delivering late phase commercial clinical trials in the NHS at pace and scale. All five Centres work collaboratively, through an innovative national franchise-like model, to make it easier and quicker to deliver commercial research in the UK.
By attracting more commercial research to the UK, PRCs also increase opportunities for NHS patients to access cutting edge treatment and therapies that are not yet widely available through the NHS. Each Centre works regionally, by partnering with their local health sector, to ensure as many people as possible are given an opportunity to take part.
The national Patient Recruitment Centres (PRCs) are a new addition to the NIHR research infrastructure - the first family of NIHR-funded research facilities to be 100% dedicated to commercial research that is funded by the life sciences industry.
The PRCs are purpose-designed to deliver phase 3 and 4 commercial trials requiring a large volume of patients. They also specialise in delivering clinical research into common chronic conditions that are often managed in primary, community, social and other non-traditional care settings by their GP, pharmacist or other AHPs.
They achieve this by using proactive and inclusive recruitment strategies to engage potential participants and by reaching out into the local community and empowering patients to volunteer for research. Through local, health-related campaigns they use a variety of methods to reach as many potential participants as possible. By adopting this approach our PRCs have the ability to reach beyond the hospital’s specialist clinics and offer research opportunities to more patients.
The PRCs are overseen by the national Programme Office based in the NIHR Clinical Research Network Coordinating Centre. Use the links below to learn more about what each centre has to offer and how you can connect:
News: Clinical Research Network; North West Coast Cancer Vacancies
News: NIHR supported studies find Novavax COVID-19 vaccine trialled in Yorkshire and Humber is 89.3% effective
News: A trial run in Devon by PRC: Exeter has given hope of adding another effective vaccine to the UK’s armoury against COVID